Skip to content
DataLookout
Menu

NCT07884903

Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Incidence of Type 2 Diabetes Mellitus
Timeframe: 3 years
Incidence of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Timeframe: 3 years
Incidence of Hypertension
Timeframe: 3 years
Incidence of Atherosclerotic Cardiovascular Disease (ASCVD)
Timeframe: 3 years

Secondary (7)

Incidence of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
Incidence of Polycystic Ovary Syndrome (PCOS)
Incidence of Osteoarticular Disease
Incidence of Hyperuricemia
Incidence of Dyslipidemia
Show 2 moreShow less
Incidence of Microalbuminuria
Progression of Prediabetes to Diabetes

Arms and interventions

Overweight

Adults with BMI 23.0-27.4 kg/m². Target enrollment: 7,785 participants.

Mild Obesity

Adults with BMI 27.5-32.4 kg/m². Target enrollment: 7,785 participants.

Moderate Obesity

Adults with BMI 32.5-37.4 kg/m². Target enrollment: 7,785 participants.

Severe Obesity

Adults with BMI ≥37.5 kg/m². Target enrollment: 2,544 participants.

Other: No intervention; observational assessment only

Sites

1 site in 1 country

  • Department of Endocrinology, Shanxi Bethune HospitalTaiyuan, Shanxi, China